BLACK DIAMOND THERAPEUTICS I's ticker is BDTX and the CUSIP is 09203E105. A total of 66 filers reported holding BLACK DIAMOND THERAPEUTICS I in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,670,383 | -70.6% | 930,447 | -48.3% | 0.06% | -69.6% |
| Q2 2023 | $9,090,000 | +41.3% | 1,800,000 | +136.8% | 0.19% | +54.0% |
| Q3 2021 | $6,431,000 | -49.6% | 760,128 | -27.4% | 0.13% | -44.5% |
| Q2 2021 | $12,770,000 | -49.8% | 1,047,599 | 0.0% | 0.23% | -57.5% |
| Q1 2021 | $25,415,000 | -1.2% | 1,047,599 | +30.5% | 0.53% | +5.1% |
| Q4 2020 | $25,720,000 | +6.0% | 802,511 | 0.0% | 0.51% | -14.0% |
| Q3 2020 | $24,260,000 | +7.4% | 802,511 | +49.7% | 0.59% | -10.2% |
| Q2 2020 | $22,598,000 | +69.0% | 536,001 | 0.0% | 0.66% | +55.2% |
| Q1 2020 | $13,373,000 | – | 536,001 | – | 0.42% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NEA Management Company, LLC | 3,449,845 | $104,289,000 | 4.42% |
| Boxer Capital, LLC | 2,014,858 | $60,909,000 | 2.10% |
| RA Capital Management | 2,589,904 | $78,293,000 | 1.43% |
| Artal Group S.A. | 1,521,517 | $45,995,000 | 1.12% |
| Ikarian Capital, LLC | 358,941 | $10,851,000 | 0.78% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 802,511 | $24,260,000 | 0.59% |
| Bellevue Group AG | 1,403,000 | $42,413,000 | 0.59% |
| Logos Global Management LP | 123,465 | $3,732,000 | 0.48% |
| Casdin Capital, LLC | 289,395 | $8,748,000 | 0.39% |
| HighVista Strategies LLC | 16,391 | $496,000 | 0.36% |